These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36811610)

  • 1. A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapy.
    Li J; Zong Q; Zhao Z; Yuan Y
    Chem Commun (Camb); 2023 Mar; 59(21):3142-3145. PubMed ID: 36811610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy.
    Wang K; Xiao X; Liu Y; Zong Q; Tu Y; Yuan Y
    Biomaterials; 2022 Oct; 289():121803. PubMed ID: 36150300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
    Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
    J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
    Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
    Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy.
    Liu Y; Jiang M; Tu Y; Wang K; Zong Q; Yuan Y
    Biomaterials; 2021 Nov; 278():121136. PubMed ID: 34562835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
    Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
    J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-boosting stimulus activation of a polyprodrug with cascade amplification for enhanced antitumor efficacy.
    Zong Q; Xiao X; Li J; Yuan Y
    Biomater Sci; 2022 Jul; 10(15):4228-4234. PubMed ID: 35758299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy.
    Liu Y; Jiang M; Zhao Z; Wang N; Wang K; Yuan Y
    Acta Biomater; 2023 Aug; 166():567-580. PubMed ID: 37207741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
    Jiang Y; Zhou Y; Zhang CY; Fang T
    Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem.
    Hu JJ; Lei Q; Peng MY; Zheng DW; Chen YX; Zhang XZ
    Biomaterials; 2017 Jun; 128():136-146. PubMed ID: 28325685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
    Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
    Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic Heterodimeric Prodrug with Dual-Channel Fluorescence Turn-On and Dual-Prodrug Activation for Synergistic Cancer Therapy.
    Jiang M; Wang K; Xiao X; Zong Q; Zheng R; Yuan Y
    Adv Healthc Mater; 2021 Nov; 10(21):e2101144. PubMed ID: 34453773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy.
    Pan Q; Deng X; Gao W; Chang J; Pu Y; He B
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111223. PubMed ID: 32615519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood circulation stable doxorubicin prodrug nanoparticles containing hydrazone and thioketal moieties for antitumor chemotherapy.
    Xu C; Xu L; Han R; Zhu Y; Zhang J
    Colloids Surf B Biointerfaces; 2021 May; 201():111632. PubMed ID: 33667865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
    Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
    Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
    Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
    Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.